PMN – promis neurosciences inc. (US:NASDAQ)
Stock Stats
News
ProMIS Neurosciences, Inc. (NASDAQ: PMN) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $6.00 price target on the stock.
ProMIS Neurosciences Announces Full Year 2024 Financial Results and Recent Highlights [Yahoo! Finance]
ProMIS Neurosciences Announces Full Year 2024 Financial Results and Recent Highlights
ProMIS Neurosciences Showcases Preclinical Data on Platform-Derived Antibody and Vaccines for Neurodegenerative Diseases at Alzheimer’s Disease/Parkinson’s Disease 2025 International Conference
ProMIS Neurosciences Showcases Preclinical Data on Platform Derived Vaccines for Neurodegenerative Diseases at the American Academy of Neurology 2025 Annual Meeting [Yahoo! Finance]
Form 424B5 ProMIS Neurosciences
Form 8-K ProMIS Neurosciences For: Mar 31
Form 10-K ProMIS Neurosciences For: Dec 31
Form 8-K ProMIS Neurosciences For: Feb 25
Form 8-K ProMIS Neurosciences For: Feb 14
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.